Stay updated on Seagen Press Releases

Sign up to get notified when there's something new on the Seagen Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Seagen Press Releases page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    No Change Detected
  6. Check
    125 days ago
    Change Detected
    Summary
    The value on the webpage has changed from Pfizer Announces Positive Overall Survival in Phase 3 Trial of ADCETRIS┬« Regimen in Patients with Relapsed/ÔÇïRefractory Diffuse Large B-cell Lymphoma (DLBCL) to Pfizer Announces New Chief Strategy and Innovation Officer. This represents a shift in focus from a clinical trial announcement to a leadership appointment within Pfizer.
    Difference
    17%
    Check dated 2024-05-07T10:15:44.000Z thumbnail image
  7. Check
    130 days ago
    Change Detected
    Summary
    The value on the webpage has changed from '03.05.2024 Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference' to 'May 2024 05.01.2024 Pfizer Reports First-Quarter 2024 Results.' This change likely represents an update in the announcement or news related to Pfizer's activities or financial results.
    Difference
    12%
    Check dated 2024-05-02T04:45:53.000Z thumbnail image
  8. Check
    132 days ago
    Change Detected
    Summary
    The value February 2024 02.29.2024 Pfizer Oncology Hosts Innovation Day, Highlighting Fully Integrated Organization, Robust Portfolio, and Strategic Priorities to Drive Long-Term Sustainable Growth 02.29.2024 Pfizer Announces Positive Top-Line Data for Full Season Two Efficacy of ABRYSVO® for RSV in Older Adults has recently changed to 04.29.2024 FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer 04.29.2024 Pfizer Highlights Progress in Accelerating Breakthrough Cancer Medicines at ASCO 2024 Annual Meeting represents the latest updates and announcements in the field of oncology and cancer treatment by Pfizer.
    Difference
    34%
    Check dated 2024-04-30T04:14:49.000Z thumbnail image
  9. Check
    135 days ago
    Change Detected
    Summary
    The value on the webpage has changed to announce that the U.S. FDA has approved Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a one-time gene therapy for adults with Hemophilia B, replacing the previous announcement about Pfizer inviting the public to listen to a webcast of a discussion at a healthcare conference.
    Difference
    16%
    Check dated 2024-04-27T02:19:26.000Z thumbnail image
  10. Check
    136 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 'European Commission Approves Pfizer’s VELSIPITY® for Patients with Moderately to Severely Active Ulcerative Colitis' to 'Pfizer Announces 2024 Shareholder Meeting Preliminary Results'. This change likely represents a shift from a product approval announcement to a shareholder meeting update or financial news.
    Difference
    11%
    Check dated 2024-04-26T02:06:49.000Z thumbnail image
  11. Check
    137 days ago
    Change Detected
    Summary
    The value on the webpage has changed from '02.15.2024 Pfizer Invites Public to Register for Webcast of Pfizer Oncology Innovation Day' to '04.24.2024 Pfizer Declares Second-Quarter 2024 Dividend'. This change represents an update from an invitation for a webcast to an announcement of a dividend declaration by Pfizer.
    Difference
    9%
    Check dated 2024-04-25T01:57:31.000Z thumbnail image

Stay in the know with updates to Seagen Press Releases

Enter your email address, and we'll notify you when there's something new on the Seagen Press Releases page.